Janssen Cilag S.A.S.
Clinical trials sponsored by Janssen Cilag S.A.S., explained in plain language.
A subsidiary of Johnson & Johnson, involved in pharmaceutical research and development.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Exercise as medicine: new trial tests if tailored workouts boost Well-Being in leukemia patients Results expected Sep 2026 (estimated)
-
Exercise as medicine: new trial tests if tailored workouts boost Well-Being in leukemia patients
Symptom relief Recruiting nowThis study is testing whether a personalized physical activity program can improve the quality of life for people with chronic lymphocytic leukemia (CLL) who are starting treatment with ibrutinib. The program includes 4 months of supervised exercise followed by 2 months of indepe…
Sponsor: Janssen Cilag S.A.S. • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Prostate cancer Pill-Taking habits under the microscope
Knowledge-focused Recruiting nowThis study tracks 270 men with metastatic hormone-sensitive prostate cancer to see how faithfully they take their apalutamide pills over the first year. Researchers will use questionnaires to measure adherence and identify who is at risk of skipping doses. The goal is to learn wh…
Sponsor: Janssen Cilag S.A.S. • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC